234 related articles for article (PubMed ID: 33081727)
1. Established fibrous peritoneal metastasis in an immunocompetent mouse model similar to clinical immune microenvironment of gastric cancer.
Fujimori D; Kinoshita J; Yamaguchi T; Nakamura Y; Gunjigake K; Ohama T; Sato K; Yamamoto M; Tsukamoto T; Nomura S; Ohta T; Fushida S
BMC Cancer; 2020 Oct; 20(1):1014. PubMed ID: 33081727
[TBL] [Abstract][Full Text] [Related]
2. Established gastric cancer cell lines transplantable into C57BL/6 mice show fibroblast growth factor receptor 4 promotion of tumor growth.
Yamamoto M; Nomura S; Hosoi A; Nagaoka K; Iino T; Yasuda T; Saito T; Matsushita H; Uchida E; Seto Y; Goldenring JR; Kakimi K; Tatematsu M; Tsukamoto T
Cancer Sci; 2018 May; 109(5):1480-1492. PubMed ID: 29532565
[TBL] [Abstract][Full Text] [Related]
3. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy.
Nagaoka K; Shirai M; Taniguchi K; Hosoi A; Sun C; Kobayashi Y; Maejima K; Fujita M; Nakagawa H; Nomura S; Kakimi K
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33093158
[TBL] [Abstract][Full Text] [Related]
4. The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer.
Tsukada T; Fushida S; Harada S; Yagi Y; Kinoshita J; Oyama K; Tajima H; Fujita H; Ninomiya I; Fujimura T; Ohta T
Int J Oncol; 2012 Aug; 41(2):476-82. PubMed ID: 22614335
[TBL] [Abstract][Full Text] [Related]
5. The peritoneal tumour microenvironment of high-grade serous ovarian cancer.
Leinster DA; Kulbe H; Everitt G; Thompson R; Perretti M; Gavins FN; Cooper D; Gould D; Ennis DP; Lockley M; McNeish IA; Nourshargh S; Balkwill FR
J Pathol; 2012 Jun; 227(2):136-45. PubMed ID: 22322968
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination.
Yamaguchi T; Fushida S; Yamamoto Y; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Tajima H; Ninomiya I; Munesue S; Harashima A; Harada S; Yamamoto H; Ohta T
Gastric Cancer; 2016 Oct; 19(4):1052-1065. PubMed ID: 26621525
[TBL] [Abstract][Full Text] [Related]
7. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
[TBL] [Abstract][Full Text] [Related]
8. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
10. Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation.
Kim EK; Yoon SO; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI
Gastric Cancer; 2017 May; 20(3):438-447. PubMed ID: 27318497
[TBL] [Abstract][Full Text] [Related]
11. Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.
Okazaki M; Fushida S; Harada S; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Ninomiya I; Ohta T
BMC Cancer; 2017 Jan; 17(1):23. PubMed ID: 28056854
[TBL] [Abstract][Full Text] [Related]
12. Gastric cancer tissue-derived mesenchymal stem cells impact peripheral blood mononuclear cells via disruption of Treg/Th17 balance to promote gastric cancer progression.
Wang M; Chen B; Sun XX; Zhao XD; Zhao YY; Sun L; Xu CG; Shen B; Su ZL; Xu WR; Zhu W
Exp Cell Res; 2017 Dec; 361(1):19-29. PubMed ID: 28964780
[TBL] [Abstract][Full Text] [Related]
13. Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis.
Li Y; Jiang L; Chen Y; Li Y; Yuan J; Lu J; Zhang Z; Liu S; Feng X; Xiong J; Jiang Y; Zhang X; Li J; Shen L
Gastric Cancer; 2024 May; 27(3):519-538. PubMed ID: 38460015
[TBL] [Abstract][Full Text] [Related]
14. Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts.
Avagliano A; Ruocco MR; Nasso R; Aliotta F; Sanità G; Iaccarino A; Bellevicine C; Calì G; Fiume G; Masone S; Masullo M; Montagnani S; Arcucci A
Cells; 2019 Nov; 8(11):. PubMed ID: 31739477
[TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling of gastric cancer with peritoneal metastasis identifies a protein signature associated with immune microenvironment and patient outcome.
Chen Y; Cai G; Jiang J; He C; Chen Y; Ding Y; Lu J; Zhao W; Yang Y; Zhang Y; Wu G; Wang H; Zhou Z; Teng L
Gastric Cancer; 2023 Jul; 26(4):504-516. PubMed ID: 36930369
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM
BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128
[TBL] [Abstract][Full Text] [Related]
17. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
18. Milky spot macrophages remodeled by gastric cancer cells promote peritoneal mesothelial cell injury.
Liu XY; Miao ZF; Zhao TT; Wang ZN; Xu YY; Gao J; Wu JH; You Y; Xu H; Xu HM
Biochem Biophys Res Commun; 2013 Sep; 439(3):378-83. PubMed ID: 23994334
[TBL] [Abstract][Full Text] [Related]
19. Senescent Fibroblasts Potentiate Peritoneal Metastasis of Diffuse-type Gastric Cancer Cells
Li Y; Tazawa H; Nagai Y; Fujita S; Okura T; Shoji R; Yamada M; Kikuchi S; Kuroda S; Ohara T; Noma K; Nishizaki M; Kagawa S; Fujiwara T
Anticancer Res; 2024 Jun; 44(6):2497-2509. PubMed ID: 38821603
[TBL] [Abstract][Full Text] [Related]
20. Unveiling the oncogenic role of CLDN11-secreting fibroblasts in gastric cancer peritoneal metastasis through single-cell sequencing and experimental approaches.
Liu K; Wang Y; Shao W; Tang C; Zhao S; Xu J; Xu P; Cheng Q; Huang S; Ji P; Qiu S
Int Immunopharmacol; 2024 Mar; 129():111647. PubMed ID: 38335659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]